Biotechnology Assets, S.A. (BME:BST)
Spain · Delayed Price · Currency is EUR 0.1950
-0.0010 (-0.51%)
Feb 6, 2026, 3:35 PM CET
Biotechnology Assets Market Cap
Biotechnology Assets has a market cap or net worth of €13.98 million as of February 6, 2026. Its market cap has decreased by -34.53% in one year.
Market Cap
13.98M
Enterprise Value
15.54M
Revenue
3.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.20
Market Cap Chart
Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 13.98M, a decrease of -81.28%. That is a compound annual growth rate of -19.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 14.33M | 2.55% |
| Dec 31, 2025 | 13.98M | -23.55% |
| Dec 31, 2024 | 18.28M | -20.03% |
| Dec 29, 2023 | 22.86M | 84.02% |
| Dec 30, 2022 | 12.42M | -40.67% |
| Dec 30, 2021 | 20.94M | -3.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.75B |
| Laboratorios Farmaceuticos Rovi | 3.76B |
| Almirall | 2.78B |
| Faes Farma | 1.63B |
| Oryzon Genomics | 250.36M |
| Laboratorio Reig Jofre | 224.64M |
| Atrys Health | 222.31M |
| Prim, S.A. | 219.51M |